Molecular Parameters for Precise Diagnosis of Asymptomatic Epstein-Barr Virus Reactivation in Healthy Carriers

Journal of Clinical Microbiology

Volumn 41, Issue 12, 2003, Pages 5419-5428

  Maurmann, Susanne ^a   Fricke, Lutz ^a   Wagner, Hans Joachim ^a   Schlenke, Peter ^a   Hennig, Holger ^a   Steinhoff, Jürgen ^a   Jabs, Wolfram J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; IMMEDIATE EARLY PROTEIN BZLF1; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD DONOR; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; IMMEDIATE EARLY GENE; IMMUNE DEFICIENCY; LYMPHOID TISSUE; MALE; MOUTH MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; VIREMIA; VIRUS CARRIER; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOOD DONORS; CARRIER STATE; DNA, COMPLEMENTARY; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL PROTEINS; VIRUS ACTIVATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0347480121     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.12.5419-5428.2003     Document Type: Article

References (36)

1. Adler, B., E. Schaadt, B. Kempkes, U. Zimber-Strobl, B. Baier, and G. W. Bornkamm. 2002. Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein1. Proc. Natl. Acad. Sci. USA 99:437-442.
2. Babcock, G. J., and D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
3. Babel, N., F. Schwarzmann, N. Prang, M. Jaeger, H. Wolf, F. Kern, H. D. Volk, and P. Reinke. 2001. Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients. Transplantation 72:736-738.
4. Brengel-Pesce, K., P. Morand, A. Schmuck, M. J. Bourgeat, M. Buisson, G. Bargues, M. Bouzid, and J. M. Seigneurin. 2002. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J. Med. Virol. 66:360-369.
5. Gan, Y., L. Sullivan, and J. W. Sixbey. 1994. Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J. Infect. Dis. 170:436-439.
6. Gleeson, M., D. B. Payne, J. P. Austin, J. Lynn Francis, R. L. Clancy, W. A. McDonald, and P. A. Fricker. 2002. Epstein-Barr virus reactivation and upper respiratory illness in elite swimmers. Med. Sci. Sports Exerc. 34:411-417.
7. Hopwood, P., L. Brooks, R. Parratt, B. J. Hunt, B. Maria, T. J. Alero, Y. Magdi, and D. H. Crawford. 2002. Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients. Transplantation 74:194-202.
8. Hornef, M. W., G. Bein, L. Fricke, J. Steinhoff, H. J. Wagner, W. Hinderer, H. H. Sonneborn, and H. Kirchner. 1995. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection and rejection episodes in renal transplant recipients. Transplantation 60:474-480.
9. Hornef, M. W., H. J. Wagner, L. Fricke, G. Bein, and H. Kirchner. 1995. Immunocytochemical detection of Epstein-Barr virus antigens in peripheral B lymphocytes after renal transplantation. Transplantation 59:138-140.
10. Ikuta, K., Y. Satoh, Y. Hoshikawa, and T. Sairenji. 2000. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect. 2:115-120.
11. Jabs, W. J., H. Hennig, M. Kittel, K. Pethig, F. Smets, P. Bucsky, H. Kirchner, and H. J. Wagner. 2001. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. J. Clin. Microbiol. 39:564-569.
12. Khan, G., E. M. Miyashita, B. Yang, G. J. Babcock, and D. A. Thorley-Lawson. 1996. Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5:173-179.
13. Kimura, H., M. Morita, Y. Yabuta, K. Kuzushima, K. Kato, S. Kojima, T. Matsuyama, and T. Morishima. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 37:132-136.
14. Mehta, S. K., D. L. Pierson, H. Cooley, R. Dubow, and D. Lugg. 2000. Epstein-Barr virus reactivation with diminished cell-mediated immunity in Antarctic expeditioners. J. Med. Virol. 61:235-240.
15. Miyashita, E., B. Yang, G. J. Babcock, and D. A. Thorley-Lawson. 1997. Identification of the site of EBV persistence in vivo as a resting B cell. J. Virol. 71:4882-4891.
16. Obel, N., M. Hoier-Madsen, and H. Kangro. 1996. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS 104:424-428.
17. Ohga, S., E. Kubo, A. Nomura, H. Takada, N. Suga, E. Ishii, A. Suminoe, T. Inamitsu, A. Matsuzaki, N. Kasuga, and T. Hara. 2001. Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting development of posttransplantation lymphoproliferative disease. Int. J. Hematol. 73:323-326.
18. Payne, D. A., S. K. Mehta, S. K. Tyring, R. P. Stowe, and D. L. Pierson. 1999. Incidence of Epstein-Barr virus in astronaut saliva during space flight. Aviat. Space Environ. Med. 70:1211-1213.
19. Prang, N. S., M. W. Hornef, M. Jäger, H. J. Wagner, H. Wolf, and F. M. Schwarzmann. 1997. Lytic replication of Epstein-Barr virus in peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665-1677.
20. Preiksaitis, J. K., F. Diaz-Mitoma, F. Mirzayans, S. Roberts, and D. L. J. Tyrrell. 1992. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and risk of posttransplant lymphoproliferative disease. J. Infect. Dis. 166:986-994.
21. Qu, L., M. Green, S. Webber, J. Reyes, E. Demetrius, and D. Rowe. 2000. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent virus loads. J. Infect. Dis. 182:1013-1021.
22. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
23. Rooney, C. M., S. K. Loftin, M. S. Holloday, M. K. Brenner, R. A. Krance, and H. Heslop. 1995. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br. J. Haematol. 89:98-103.
24. Schaade, L., M. Kleines, and M. Haüsler. 2001. Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood. J. Clin. Microbiol. 39:3902-3905.
25. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Immunol. 1:75-82.
26. Tovey, M. G., G. Lenoir, and J. Begon-Lours. 1978. Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276:270-272.
27. Vajro, P., S. Lucariello, F. Migliaro, E. Sokal, B. Gridelli, A. Vegnente, R. Iorio, F. Smets, I. Quinto, and G. Scala. 2000. Predictive value of Epstein-Barr virus genome copy number and BZLF1 expression in blood lymphocytes of transplant recipients at risk for lymphoproliferative disease. J. Infect. Dis. 181:2050-2054.
28. Venard, V., A. S. Carret, N. Pascal, B. Rihn, P. Bordigoni, and A. Le Faou. 2000. A convenient semi-quantitative method for the diagnosis of Epstein-Barr virus reactivation. Arch. Virol. 145:2211-2216.
29. Wagner, H. J., G. Bein, A. Bitsch, and H. Kirchner. 1992. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-sero-positive, healthy individuals by polymerase chain reaction. J. Clin. Microbiol. 30:2826-2829.
30. Wagner, H. J., L. Fischer, W. J. Jabs, M. Holbe, K. Pethig, and P. Bucsky. 2002. Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation 74:656-664.
31. Wagner, H. J., M. Hornef, J. Feldner, and H. Kirchner. 1994. Determination of IgG- and IgM-antibodies to Epstein-Barr virus associated antigens in blood donors by a novel enzyme-linked immunosorbent assay. Lab. Med. 18:165-167.
32. Wagner, H. J., W. Jabs, F. Smets, M. Wessel, L. Fischer, G. Offner, H. Kirchner, and P. Bucsky. 2000. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells. Klin. Padiatr. 212:206-210.
33. Wagner, H. J., M. Wessel, W. Jabs, F. Smets, L. Fischer, G. Offner, and P. Bucsky. 2001. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 72:1-8.
34. Wandinger, K., W. Jabs, A. Siekhaus, S. Bubel, P. Trillenberg, H. Wagner, K. Wessel, H. Kirchner, and H. Hennig. 2000. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55:178-184.
35. Yang, J., Q. Tao, I. W. Flinn, P. G. Murray, L. E. Post, H. Ma, S. Piantadosi, M. A. Caligiuri, and R. F. Ambinder. 2000. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 96:4055-4063.
36. Yao, Q. Y., A. B. Rickinson, and M. A. Epstein. 1985. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int. J. Cancer 35:35-42.